281 related articles for article (PubMed ID: 9425398)
1. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity.
Fernández-Real JM; Ricart W; Casamitjana R
Clin Endocrinol (Oxf); 1997 Nov; 47(5):583-8. PubMed ID: 9425398
[TBL] [Abstract][Full Text] [Related]
2. Cortisol levels during an oral glucose tolerance test in lean and obese women.
Cakir M; Sari R; Tosun O; Karayalcin U
Endocr Res; 2005; 31(3):213-8. PubMed ID: 16392623
[TBL] [Abstract][Full Text] [Related]
3. The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women.
Fernández-Real JM; Grasa M; Casamitjana R; Ricart W
Clin Endocrinol (Oxf); 2000 Jan; 52(1):93-9. PubMed ID: 10651759
[TBL] [Abstract][Full Text] [Related]
4. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
[TBL] [Abstract][Full Text] [Related]
5. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome.
Hautanen A; Adlercreutz H
J Intern Med; 1993 Nov; 234(5):461-9. PubMed ID: 8228790
[TBL] [Abstract][Full Text] [Related]
6. Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans.
Fernández-Real JM; Sanchis D; Ricart W; Casamitjana R; Balada F; Remesar X; Alemany M
Clin Endocrinol (Oxf); 1999 Feb; 50(2):253-60. PubMed ID: 10396370
[TBL] [Abstract][Full Text] [Related]
7. Simple skinfold-thickness measurements complement conventional anthropometric assessments in predicting glucose tolerance.
Sievenpiper JL; Jenkins DJ; Josse RG; Leiter LA; Vuksan V
Am J Clin Nutr; 2001 Mar; 73(3):567-73. PubMed ID: 11237933
[TBL] [Abstract][Full Text] [Related]
8. Leptin is involved in gender-related differences in insulin sensitivity.
Fernández-Real JM; Casamitjana R; Ricart-Engel W
Clin Endocrinol (Oxf); 1998 Oct; 49(4):505-11. PubMed ID: 9876349
[TBL] [Abstract][Full Text] [Related]
9. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
10. Relationship between insulin sensitivity, obesity, body fat distribution and beta-endorphinaemia in obese women.
Percheron C; Colette C; Mariano-Goulart D; Avignon A; Capeyron O; Boniface H; Bressot N; Monnier L
Int J Obes Relat Metab Disord; 1998 Feb; 22(2):143-8. PubMed ID: 9504322
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
Del Rio G; Procopio M; Bondi M; Marrama P; Menozzi R; Oleandri SE; Grottoli S; Maccario M; Velardo A; Ghigo E
Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1111-4. PubMed ID: 9426377
[TBL] [Abstract][Full Text] [Related]
12. Serum ferritin as a component of the insulin resistance syndrome.
Fernández-Real JM; Ricart-Engel W; Arroyo E; Balançá R; Casamitjana-Abella R; Cabrero D; Fernández-Castañer M; Soler J
Diabetes Care; 1998 Jan; 21(1):62-8. PubMed ID: 9580307
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
14. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome.
Pasquali R; Gagliardi L; Vicennati V; Gambineri A; Colitta D; Ceroni L; Casimirri F
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):419-24. PubMed ID: 10340821
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular disease.
Cefalu WT; Werbel S; Bell-Farrow AD; Terry JG; Wang ZQ; Opara EC; Morgan T; Hinson WH; Crouse JR
Metabolism; 1998 Apr; 47(4):401-8. PubMed ID: 9550536
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
17. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males.
Hautanen A; Räikkönen K; Adlercreutz H
J Intern Med; 1997 Jun; 241(6):451-61. PubMed ID: 10497620
[TBL] [Abstract][Full Text] [Related]
18. Morning cortisol levels and glucose effectiveness.
Fernández-Real JM; Casamitjana R; Ricart W
Metabolism; 2000 Mar; 49(3):305-7. PubMed ID: 10726905
[TBL] [Abstract][Full Text] [Related]
19. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships.
Zamboni M; Armellini F; Milani MP; De Marchi M; Todesco T; Robbi R; Bergamo-Andreis IA; Bosello O
Int J Obes Relat Metab Disord; 1992 Jul; 16(7):495-504. PubMed ID: 1323546
[TBL] [Abstract][Full Text] [Related]
20. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
